Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
A recent study published in the Annals of Epidemiology found that diabetes and postmenopausal surgery are associated with kidney stone disease (KSD).
Read Full NewsClinical Forum Weighs in: Biologic Selection in Asthma and COPD
Treatable Traits in Asthma and COPD: Clinical Forum Perspectives
Biologic Access in Asthma and COPD: Clinical Forum Perspectives
The designation follows phase 2 ClearMEMory data in which the oral NMDA receptor antagonist improved objective cognitive performance over placebo at 12 weeks.
A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key results that matter for practice.
The phase 1 ASCEND trial is testing a single intrathecal dose of the investigational AAV9 gene therapy INS1201 in young boys with Duchenne muscular dystrophy.
Findings from the phase 3 METEOROID trial showed that satralizumab reduced the risk of relapse in patients with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.
1.
Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments
2.
GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium
3.
More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
4.
Mutation Correlates with a Higher Prostate Cancer Mortality Risk.
5.
Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer
1.
Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy
2.
Integrated Trends in Hematology for Modern Medicine
3.
Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant
4.
Essential Strategies in Hematology for Healthcare Excellence
5.
Reconstructive Tissue Engineering After Tumor Resection
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
2.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part XIII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge